Health News

Vorstellung neuer Daten zu Zonegran® (Zonisamid), Fycompa® (Perampanel) und Zebinix® (Eslicarbazepinacetat) auf dem World Congress of Neurology

Author: Australian Business

HATFIELD, Großbritannien, September 21, 2013 /PRNewswire/ -- PRESSEMITTEILUNG NUR FÜR EUROPÄISCHE MEDIEN, NICHT FÜR US-MEDIEN Eisai beweist sein Engagement für kontinuierliche Forschung auf dem Gebiet der Epilepsie Auf dem diesjährigen World Congress of......

More...

More Articles...

De nouvelles données concernant Zonegran® (zonisamide), Fycompa® (pérampanel) et Zebinix® (eslicarbazépine acétate) presentées au congrès mondial de neurologie
Nuevos datos sobre Zonegran® (zonisamida), Fycompa® (perampanel) y Zebinix® (acetato de eslicarbazepina) que se presentarán en el Congreso Mundial de Neurología
Exclusive ACE salt water system and unprecedented savings make it easy to get "In the Water" of a Hot Spring spa
Radiation Business Solutions Reviews Year-To-Date Progress, Welcomes New President
Nutranomics completes Name Change and closes Acquisition of Nutraceutical Company
OPTIMIZERx Corporation Announces the Resignation of the Company's Current CEO Chairman Mr. Shadron L. Stastney
Affordable IVF Delivers It's First Baby
Rogers Sponsors "Experience the Power of Experiential Therapy" at the 2013 National Conference on Addiction Disorders
Vital Access Corp. Announces First U.S. Commercial Implantation Of VWING™ Vascular Needle Guide
Veracyte, Inc. Files Registration Statement for Initial Public Offering

Page 1558 of 1908